Chimeric Therapeautics Ltd (PK) (CHMMF)
USOTC
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 0 | 0 | 2.62M | 4.51M | 9.61M |
Operating Income | -64k | -14.85M | -14.57M | -24.98M | -11.03M |
Pre Tax Income | -64k | -15.11M | -15.74M | -25.82M | -12.52M |
Net Income | -64k | -15.11M | -15.9M | -25.92M | -12.53M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.064 | -0.046 | -0.037 | -0.051 | -0.014 |
EBIT | -64k | -14.85M | -14.57M | -25.08M | -12.36M |
EBITDA | -64k | -14.84M | -14.57M | -24.97M | -11.03M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.